International Clinical Trial: Efficacy and Safety of Oral Semaglutide for Weight Control in Overweight or Obese HIV Patients Receiving Long-Term Integrase Inhibitor-Based Antiretroviral Therapy: A Multicenter, Prospective Cohort Study

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120002) titled 'Efficacy and Safety of Oral Semaglutide for Weight Control in Overweight or Obese HIV Patients Receiving Long-Term Integrase Inhibitor-Based Antiretroviral Therapy: A Multicenter, Prospective Cohort Study' on March 6.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing Ditan Hospital, Capital Medical University

Condition: Acquired Immunodeficiency Syndrome

Intervention: Oral Semaglutide Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-06

Target Sample Size: Oral Semaglutide Group:40;Non-Semaglutide Group:40;

Countries of Re...